Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuan Yi Biotechnology is a Chinese synthetic biology company specializing in the microbial production of high-value natural products for the healthcare, nutrition, and pharmaceutical industries. The company utilizes its proprietary Microbial Cell Factory platform to engineer microorganisms for the sustainable biosynthesis of complex molecules, such as astaxanthin and zeaxanthin. By leveraging advanced metabolic engineering and fermentation technologies, Yuan Yi provides a green, cost-effective alternative to traditional chemical synthesis and plant extraction methods. The company's product portfolio is expanding to include pharmaceutical intermediates and functional food ingredients aimed at addressing oxidative stress and eye health. Supported by prominent investors like Hillhouse Capital and Matrix Partners, Yuan Yi is scaling its industrial-grade manufacturing capabilities to serve global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuan Yi Biotechnology.